Creatine Monohydrate as Adjuvant Therapy for Bipolar Depression

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether creatine monohydrate is effective as an adjuvant treatment for bipolar depression.

Clinical Trial Description

Bipolar Depression is associated with high rates of disability and increased mortality. Despite its major negative impact, treatment of Bipolar Depression is still controversial and only partially efficacious, with over half of patients not responding adequately to available treatment. In this context, the use of drugs that modulate energy metabolism has been proposed as promising new option as treatment strategies for bipolar depression. The aim of our proposed study is to perform a 6-week randomized, double-blind, placebo-controlled clinical trial of creatine monohydrate as an adjuvant treatment for bipolar depression. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01655030
Study type	Interventional
Source	University of Sao Paulo
Contact
Status	Completed
Phase	N/A
Start date	July 2012
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03641300` - Efficacy of Convulsive Therapies for Bipolar Depression	N/A
Withdrawn	`NCT01495156` - Study of the Efficacy of Adjunctive Lithium Treatment for the Treatment of Psychotic Mania	Phase 4
Completed	`NCT00982020` - Study in Adolescents With Schizophrenia or Bipolar Disorder	Phase 4
Completed	`NCT00746343` - Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study	N/A
Completed	`NCT00177463` - L-Carnosine for Bipolar I Disorder	N/A
Completed	`NCT03257865` - A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder	Phase 3
Completed	`NCT03259555` - A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder	Phase 3
Not yet recruiting	`NCT06433635` - Sequential Multiple Assignment Randomized Trial for Bipolar Depression	Phase 4
Completed	`NCT04127058` - Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia	Phase 1
Recruiting	`NCT05977023` - NMDA Receptor Modulation for the Treatment of Bipolar I Disorder	Phase 2
Recruiting	`NCT05340686` - Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression	N/A
Completed	`NCT03287869` - A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.	Phase 3
Enrolling by invitation	`NCT04987229` - Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects	Phase 3
Completed	`NCT00761761` - Sensoril(Ashwaganhda)for Bipolar Disorder	Phase 3
Completed	`NCT00232414` - A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder	Phase 3
Completed	`NCT03292848` - Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders	Phase 1
Active, not recruiting	`NCT04561622` - Emotional Proactive Processing in Bipolar Disorder
Recruiting	`NCT03943537` - Effects of Intranasal Insulin on Neuroimaging Markers and Cognition in Patients With Psychotic Disorders	Phase 2
Completed	`NCT03334721` - Gabapentin for Bipolar & Cannabis Use Disorders	Phase 2
Active, not recruiting	`NCT05658510` - Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)	Phase 3